IMBALANCED CYTOKINE PRODUCTION BY MACROPHAGES FROM AUTOIMMUNE-PRONE MICE

被引:29
作者
LEVINE, J
HARTWELL, D
BELLER, DI
机构
[1] BOSTON UNIV, MED CTR, DEPT MED, RES IMMUNOL UNIT, BOSTON, MA 02118 USA
[2] BOSTON UNIV, MED CTR, DEPT MED, RENAL SECT, BOSTON, MA 02118 USA
[3] BOSTON UNIV, MED CTR, EVANS DEPT CLIN RES, BOSTON, MA 02118 USA
关键词
AUTOIMMUNITY; MACROPHAGE; CYTOKINE; INTERLEUKIN-1; INTERLEUKIN-6; TUMOR NECROSIS FACTOR-ALPHA;
D O I
10.1016/0165-2478(91)90023-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Peritoneal macrophages from multiple autoimmune-prone strains of mice (MRL/lpr, MRL/+, NZB/W, BXSB, and B6/gld) show defective expression of the cytokines IL-1 and IL-6. Autoimmune mice were all used between 1 and 6 weeks of age, the earliest times being well before the onset of overt disease. Northern blot analysis reveals a parallel reduction in the levels of IL-1-alpha, IL-1-beta, and IL-6 mRNA. In contrast, the production of other proteins, including the cytokine TNF-alpha, appears to be normal. These findings imply an imbalance within the cytokine network of autoimmune macrophages. Studies on bone marrow-derived macrophage precursors, as well as macrophages from chimeric mice, suggest an intrinsic macrophage defect as opposed to conditioning by the autoimmune environment. This defect appears to be constant throughout the lifespan of autoimmune MRL/lpr mice, being equally apparent in 1-week old mice as in fully diseased 6-12-month-old mice. Aberrant regulation of IL-1 and IL-6 represents a novel defect in the function of autoimmune macrophages that is both intrinsic and substantial, and has the potential to contribute to the immune dysregulation that characterizes autoimmunity.
引用
收藏
页码:183 / 192
页数:10
相关论文
共 43 条
[11]  
DONNELLY RP, 1990, J IMMUNOL, V145, P3231
[12]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13
[13]   COMPARISON OF INVITRO-CELL CYTO-TOXIC ASSAYS FOR TUMOR NECROSIS FACTOR [J].
FLICK, DA ;
GIFFORD, GE .
JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 68 (1-2) :167-175
[14]   CHRONIC THERAPY WITH RECOMBINANT TUMOR NECROSIS FACTOR-ALPHA IN AUTOIMMUNE NZB/NZW F1-MICE [J].
GORDON, C ;
RANGES, GE ;
GREENSPAN, JS ;
WOFSY, D .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1989, 52 (03) :421-434
[15]  
GORDON C, 1990, J IMMUNOL, V144, P1753
[17]   ENHANCING EFFECT OF H-2-LINKED NZW GENE(S) ON THE AUTOIMMUNE TRAITS OF (NZB X NZW)F1 MICE [J].
HIROSE, S ;
NAGASAWA, R ;
SEKIKAWA, I ;
HAMAOKI, M ;
ISHIDA, Y ;
SATO, H ;
SHIRAI, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (01) :228-233
[18]  
HORII Y, 1989, J IMMUNOL, V143, P3949
[19]   PREVENTION OF DIABETES IN NONOBESE DIABETIC MICE BY TUMOR NECROSIS FACTOR (TNF) - SIMILARITIES BETWEEN TNF-ALPHA AND INTERLEUKIN-1 [J].
JACOB, CO ;
AISO, S ;
MICHIE, SA ;
MCDEVITT, HO ;
ACHAORBEA, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (03) :968-972
[20]   TUMOR NECROSIS FACTOR-ALPHA IN MURINE AUTOIMMUNE LUPUS NEPHRITIS [J].
JACOB, CO ;
MCDEVITT, HO .
NATURE, 1988, 331 (6154) :356-358